Acetyl-CoA synthetases ACSS1 and ACSS2 are 4-hydroxytamoxifen responsive factors that promote survival in tamoxifen treated and estrogen deprived cells

por Calhoun, Sarah, Duan, Lei, Maki, Carl G.
Publicado 2022

RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC

por Duan, Lei, Perez, Ricardo E., Calhoun, Sarah, Maki, Carl G.
Publicado 2022

Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradat...

por Duan, Lei, Perez, Ricardo E., Calhoun, Sarah, Maki, Carl G.
Publicado 2022

Author Correction: RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC

por Duan, Lei, Perez, Ricardo E., Calhoun, Sarah, Maki, Carl G.
Publicado 2022

Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells

por Duan, Lei, Calhoun, Sarah, Shim, Daeun, Perez, Ricardo E, Blatter, Lothar A, Maki, Carl G
Publicado 2021

Corrigendum to ‘Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells’

por Duan, Lei, Calhoun, Sarah, Shim, Daeun, Perez, Ricardo E, Blatter, Lothar A, Maki, Carl G
Publicado 2022

Prolylcarboxypeptidase promotes IGF1R/HER3 signaling and is a potential target to improve endocrine therapy response in estrogen receptor positive breast cancer

por Duan, Lei, Calhoun, Sarah J., Perez, Ricardo E., Macias, Virgilia, Mir, Fatima, Gattuso, Paolo, Maki, Carl G.
Publicado 2022

Prolyl Carboxypeptidase Maintains Receptor Tyrosine Kinase Signaling and Is a Potential Therapeutic Target in Triple Negative Breast Cancer

por Duan, Lei, Calhoun, Sarah, Perez, Ricardo E., Macias, Virgilia, Mir, Fatima, Pergande, Melissa R., Gattuso, Paolo, Borgia, Jeffrey A., Maki, Carl G.
Publicado 2022